Bernhardt K, McClune W, Rowland MJ, Shah A. Hypertonic saline versus other intracranial-pressure-lowering agents for patients with acute traumatic brain injury: a systematic review and meta-analysis. Neurocrit Care. 2023. https://doi.org/10.1007/s12028-023-01771-9.

Article  PubMed  Google Scholar 

Seethapathy H, Zhao S, Ouyang T, et al. Severe hyponatremia correction, mortality and central pontine myelinolysis. NEJM Evid. 2023. https://doi.org/10.1056/EVIDoa2300107.

Article  Google Scholar 

Baek SH, Jo YH, Ahn S, et al. Risk of overcorrection in rapid intermittent bolus vs slow continuous infusion therapies of hypertonic saline for patients with symptomatic hyponatremia: the SALSA randomized clinical trial. JAMA Intern Med. 2021;181:81–92.

Article  CAS  PubMed  Google Scholar 

Roquilly A, Moyer JD, Huet O, et al. Effect of continuous infusion of hypertonic saline vs standard care on 6-month neurological outcomes in patients with traumatic brain injury: the COBI randomized clinical trial. JAMA. 2021;325:2056–66.

Article  CAS  PubMed  Google Scholar 

Rowland MJ, Veenith T, Scomparin C, et al. “Sugar or Salt” (SOS) trial protocol summary. J Intensive Care Soc. 2022;23:492.

Article  PubMed  Google Scholar